{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": -3.3333302, "regularMarketPrice": 11.6, "exchange": "FRA", "shortName": "IGM BIOSCIENCES  DL-,01", "longName": "IGM Biosciences, Inc.", "messageBoardId": "finmb_315179920", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683899564, "earningsTimestamp": 1683896700, "earningsTimestampStart": 1683896700, "earningsTimestampEnd": 1683896700, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.7, "epsForward": -6.26, "epsCurrentYear": -5.03, "priceEpsCurrentYear": -2.306163, "sharesOutstanding": 29508100, "bookValue": 6.668, "fiftyDayAverage": 14.094, "fiftyDayAverageChange": -2.4939995, "fiftyDayAverageChangePercent": -0.1769547, "twoHundredDayAverage": 18.478, "twoHundredDayAverageChange": -6.8780003, "twoHundredDayAverageChangePercent": -0.37222645, "marketCap": 509634432, "forwardPE": -1.8530351, "priceToBook": 1.739652, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1568786400000, "priceHint": 2, "regularMarketChange": -0.39999962, "regularMarketDayHigh": 11.8, "regularMarketDayRange": "11.6 - 11.8", "regularMarketDayLow": 11.6, "regularMarketVolume": 40, "regularMarketPreviousClose": 12.0, "bid": 11.3, "ask": 11.5, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 11.8, "averageDailyVolume3Month": 9, "averageDailyVolume10Day": 4, "fiftyTwoWeekLowChange": 2.7000008, "fiftyTwoWeekLowChangePercent": 0.3033709, "fiftyTwoWeekRange": "8.9 - 26.6", "fiftyTwoWeekHighChange": -15.0, "fiftyTwoWeekHighChangePercent": -0.56390977, "fiftyTwoWeekLow": 8.9, "fiftyTwoWeekHigh": 26.6, "symbol": "1K0.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "325 East Middlefield Road", "city": "Mountain View", "state": "CA", "zip": "94043", "country": "United States", "phone": "(650) 965-7873", "website": "https://igmbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's product candidate, including imvotamab (IGM-2323), an IgM-based CD20 x CD3 bispecific antibody T cell engager that is in Phase 2 clinical trials for the treatment of B cell non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1a/1b clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody that is in Phase 1 clinical trials for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.", "fullTimeEmployees": 258, "companyOfficers": [{"maxAge": 1, "name": "Mr. Fred M. Schwarzer J.D.", "age": 69, "title": "CEO, Pres & Director", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": {"raw": 977658, "fmt": "977.66k", "longFmt": "977,658"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 4365618, "fmt": "4.37M", "longFmt": "4,365,618"}}, {"maxAge": 1, "name": "Dr. Bruce A. Keyt", "age": 69, "title": "Chief Scientific Officer", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": {"raw": 692954, "fmt": "692.95k", "longFmt": "692,954"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3441786, "fmt": "3.44M", "longFmt": "3,441,786"}}, {"maxAge": 1, "name": "Dr. Chris H. Takimoto FACP, M.D., Ph.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 684953, "fmt": "684.95k", "longFmt": "684,953"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Misbah  Tahir", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2019, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Steven  Weber", "age": 46, "title": "Sr. VP, Corp. Controller & Principal Accounting Officer", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul C. Graffagnino", "title": "VP of Legal Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Suzette  Tauber", "age": 58, "title": "Chief HR Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Shinyu  Chen M.D., Ph.D.", "age": 53, "title": "Consultant", "yearBorn": 1969, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Angus M. Sinclair Ph.D.", "title": "Sr. VP of Immuno-Oncology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lisa L. Decker Ph.D.", "age": 53, "title": "Chief Bus. Officer", "yearBorn": 1969, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}